Authors
Latest:
Keeping Oncologists Current Through the Power of EducationAccording to the Centers for Disease Control and Prevention (CDC), lung cancer is the leading cause of cancer death in both men and women in the US, with about 228,150 new cases diagnosed in 2019 and approximately 143,000 deaths reported annually.
Latest:
Privacy-Safe Analytics and AI Will Accelerate Shift to Patient-Centered HealthcareHow successful commercial teams will balance the continued shift toward personalized medicine and the increased concentration on data privacy.
Latest:
Turning Detailed Drug Profiles into Targeted Business InsightsHaving invested heavily in new regulatory database systems, life sciences firms owe it to themselves to capitalize on the insights locked within those rich data assets, writes David Gwyn.
Latest:
Large Pharma Tries New Approach to Non-AdherenceMedication non-adherence is a real problem, this article looks at how to help patients better control their treatments and improve adherence.
Latest:
Digital Drives Customer-Centric Sales EngagementHow digital is helping companies increase call volumes, access to HCPs, and HCP-led dialogue.
Latest:
Preparing for Competitive Challenges to Biologics with Expiring Market ExclusivityGuidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.
Latest:
Preparing for Competitive Challenges to Biologics with Expiring Market ExclusivityGuidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.
Latest:
Practically Speaking: Driving Clinical TransformationThis video series discusses the impact of implementing risk-based quality management (RBQM) and decentralized clinical trials (DCTs) from the clinical operations point of view.
Latest:
The Roots and Rise of Cell and Gene TherapyContinued investment will mean new cures in a new decade.
Latest:
The Roots and Rise of Cell and Gene TherapyContinued investment will mean new cures in a new decade.
Latest:
Using Service to Drive Commercial ValueOne ‘team’ model’s advantages in brand outreach and awareness.
Latest:
Education: The Creative DifferentiatorEverything has an MOA. Bourbon has an MOA. There’s nothing unique about that. What’s differentiating is the benefit associated with the molecule’s MOA.
Latest:
Critical Connection: Patient Services and Product LaunchA look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.
Latest:
Critical Connection: Patient Services and Product LaunchA look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.
Latest:
Prescribing Patterns: How to Get Ahead of the TrendsThe key to success in a hypercompetitive marketplace is to create targeting plans that get ahead of tomorrow’s prescriptions.
Latest:
Towards a Multichannel Marketing CultureThe biggest challenge to becoming a multi-channel marketing organization is not a company's technology, it’s the culture, write Melissa Dimitri, Larry Smith, Laurel Fitts, and Mark Trybulski.
Latest:
The Brexit Deal and the Life Sciences SectorOn December 24, 2020, the UK finally agreed a Trade and Cooperation Agreement (TCA) with the EU. Cliodhna McDonough offers some initial thoughts on the implications of the TCA on the life sciences sector.
Latest:
Transforming the CIO Role to Embrace Digital HealthStrategies for those chief information officers taking the digital reins at their organizations.
Latest:
Forget Selecting a Site — Now the Site Selects YouPost-approval studies, at many companies, do not have a consistent strategy that builds networks of investigators.
Latest:
Commercializing an Orphan Drug: Why “Just” Serving a High Unmet Medical Need Won’t Do the JobLooking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug
Latest:
A Contingent Workforce Strategy Is Critical to Life Sciences CompaniesSpeed to market is crucial to the success of launching new products and therapies.
